G-Lp1 Cravings Supppression Vials Peptides Cagrisema for Weight Loss Factory Supplier 99% Raw Finished Powder Peptides Cagrisema for Type 2 Diabetes Treatment

• Customization: Available
• CAS No.: 1415456-99-3
• Formula: C187h291n45o59
• Model NO.: Cagrisema
• Type: Pharmaceutical Intermediates
• Appearance: Powder
• Quality: Technical
• Colour: White
• Name: Cagrisema
• Mf: C50h69n15o9
• MW: 1024.18
• CAS: 1415456-99-3
• Packing: 10vials/Box
• Usage: for Research Use Only
• Suitable for: Elderly, Adult
• Transport Package: Customized Request
• Specification: 5mg/vial; 10mg/vial; 15mg/vial; 30mg/vial
• Trademark: RDG
• Origin: China
• Production Capacity: 50000vials

Product Description

G-Lp1 Cravings Supppression Vials Peptides Cagrisema for Weight Loss Factory Supplier 99% Raw Finished Powder Peptides Cagrisema for Type 2 Diabetes Treatment

Product name	Cagrisema
Appearance	White powder
Purity	99%
Storage	Keep in a cool, dry, dark location in a tightly sealed container or cylinder.
Shelf Life	24 Months

Application:

Novel weight loss peptides were approved by the FDA for weight loss in late 2014. It's a newer class of drugs better known

for its ability to improve blood sugar control. These medications were actually designed to treat type II diabetes,

but some have also been FDA approved to treat weight loss. The G-LP-1 agonists we work with are called Sema

& Tirze.

Tirze is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and

glucagon-like peptide-1 receptor. It showed glucose control and weight loss in patients with type 2 diabetes mellitus (T2DM).

It can be used for the research of obesity.

Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,

please refer to the manual:Handling and Storage of Synthetic Peptides.

Retatrutide is a triple glucagon, GIP, and GLP receptor agonist. Retatrutide showed glucose control and weight loss in patients

with type 2 diabetes mellitus (T2DM).

What Is Retatrutide?

Retatrutide (LY3437943) is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide

receptor (GIPR), and glucagon-like peptide-1 receptor.Retatrutide can be used for the research of obesity.

Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details,

please refer to the manual:Handling and Storage of Synthetic Peptides.

For Research Purpose Only. Purchasing objects are required to be companies and labs, not for personal use.